Adam M. Brufsky
Advanced in Caffey Disease
Advanced in Caffey Disease
300 Halket Street, Suite 4628, 
Pittsburgh, PA 

Overview

Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center. Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute. Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program.

Dr. Brufsky is rated as an Advanced provider by MediFind in the treatment of Caffey Disease. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Gastrostomy.

His clinical research consists of co-authoring 331 peer reviewed articles and participating in 45 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Licenses
Specialist in PA
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine
Fellowships
Dana Farber Cancer Institute
Hospital Affiliations
Magee Womens Hospital Of Upmc Health System
Upmc Presbyterian Shadyside
Upmc Jameson
Upmc Passavant
Upmc East
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Nippon Life
  • INSURANCE PLAN
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

UPMC Hillman Cancer Center
300 Halket Street, Suite 4628, Pittsburgh, PA 15213

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


39 Clinical Trials

I-SPY Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2)
Genomically-Guided Treatment Trial in Brain Metastases
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
Molecular Analysis for Therapy Choice (MATCH)
(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
Phase II Trial of Radium-223 Dichloride in Combination With Paclitaxel in Patients With Bone Metastatic Breast Cancer
View 37 Less Clinical Trials
Similar Doctors
Priya Rastogi
Advanced in Caffey Disease
Hematology Oncology
Advanced in Caffey Disease
Hematology Oncology

UPMC Hillman Cancer Center

300 Halket Street, Suite 4628, 
Pittsburgh, PA 
 (0.1 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Priya Rastogi, MD, is currently Associate Professor of Medicine at the University of Pittsburgh School of Medicine. Dr. Rastogi received a Bachelor of Arts degree in Chemistry from Miami University at Oxford, Ohio. She earned her MD at Wright State University School of Medicine in Dayton, Ohio and completed her residency in Internal Medicine at Saint Joseph's Hospital in Denver, Colorado, where she received the Resident of the Year Award. Her Fellowship was completed at the University of Pittsburgh School of Medicine in Pittsburgh, PA. During her fellowship, Dr. Rastogi's research was focused on Herceptin-induced cardiotoxicity, and she was awarded a grant from the National Surgical Breast and Bowel Project. Dr. Rastogi is board certified in Internal Medicine and Medical Oncology by the American Board of Internal Medicine. She is an associate member of the American Society of Clinical Oncology and the American Association for Cancer Research. She has several abstracts and research articles in leading journals, including Seminars in Breast Disease, Oncology, and Diseases of the Breast. Dr. Rastogi practices in the Womens Cancer Center at Magee-Womens Hospital will see over 125 new breast cancer consultations and over 1250 patient visits in 2004. Dr. Rastogi has participated in the Introduction to Being a Physician course for first year medical students at the University of Pittsburgh School of Medicine for two years and is also active within the community for lectures and presentations. Dr. Rastogi is rated as an Advanced provider by MediFind in the treatment of Caffey Disease. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Caffey Disease.

Shannon L. Puhalla
Experienced in Caffey Disease
Hematology Oncology
Experienced in Caffey Disease
Hematology Oncology

UPMC Hillman Cancer Center

300 Halket Street, 
Pittsburgh, PA 
 (0.6 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Shannon L. Puhalla, MD, is assistant professor of medicine at the University of Pittsburgh School of Medicine, and a medical oncologist and hematologist at UPMC Hillman Cancer Center. She specializes in breast oncology, Phase I clinical trials, and novel therapeutics in breast cancer. Dr. Puhalla is rated as a Distinguished provider by MediFind in the treatment of Caffey Disease. Her top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Breast Cancer.

Vikram C. Gorantla
Experienced in Caffey Disease
Hematology Oncology
Experienced in Caffey Disease
Hematology Oncology

UPMC Hillman Cancer Center

300 Halket Street, 
Pittsburgh, PA 
 (0.6 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Vikram C. Gorantla, MD, specializes in the treatment of sarcoma, breast cancer, gastrointestinal malignancies, and head and neck cancers. Board-certified in internal medicine and medical oncology, he received his medical degree at the University of Texas Southwestern Medical School in Dallas. He completed his internal medicine residency at Washington University, St. Louis, MO, and his hematology/oncology fellowship at UPMC. Dr. Gorantla has a dedicated day seeing breast cancer patients at the Magee-Womens Cancer Progam. He also collaborates with surgical oncologists and gynecologists/oncologists to provide multidisciplinary care to patients. Dr. Gorantla is rated as a Distinguished provider by MediFind in the treatment of Caffey Disease. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Ampullary Cancer, Gamma Knife Radiosurgery, and Endoscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Brufsky's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 32 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile